Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Seattle at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
The main purpose of this study is to investigate the safety, tolerability, preliminary efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of biomarker-guided novel anticancer agent(s) as monotherapy or combination therapy for the treatment of participants with advanced/recurrent ovarian cancer. Substudy 1 will investigate the safety, tolerability, preliminary efficacy, PK and PD of saruparib monotherapy in participants with BReast CAncer gene (BRCA) mutated epithelial ovarian, fallopian
Sponsor: AstraZeneca
Check if you qualify for this ovarian cancer clinical trial in Seattle, WA
If you're searching for ovarian cancer treatment options in Seattle, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.